Prognostic significance of p16, p53, Bcl-2, and Bax in oral and oropharyngeal squamous cell carcinoma

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90.10.3322/caac.20107Open DOISearch in Google Scholar

2. Khuhaprema T, Srivatanakul P, Attasara P, Sriplung H, Wiangnon S, Sumitsawan Y. Cancer in Thailand Vol. V, 2001-2003. Bangkok; 2010.Search in Google Scholar

3. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005; 114:806-16.10.1002/ijc.20740Open DOISearch in Google Scholar

4. Korsmeyer SJ. Regulators of cell death. Trends Genet. 1995; 11:101-5.10.1016/S0168-9525(00)89010-1Open DOISearch in Google Scholar

5. Hall PA, Meek D, Lane DP. p53-integrating the complexity. J Pathol. 1996; 180:1-5.10.1002/(SICI)1096-9896(199609)180:1<1::AID-PATH712>3.0.CO;2-UOpen DOISearch in Google Scholar

6. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994; 9:1799-805.Search in Google Scholar

7. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993; 366:704-7.10.1038/366704a0Search in Google Scholar

8. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. Engl J Med. 2001; 344:1125-31.10.1056/NEJM200104123441503Search in Google Scholar

9. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck. 2013; 35:747-55.10.1002/hed.22015Open DOISearch in Google Scholar

10. Klussmann JP, Weissenborn S, Wieland U, Dries V, Kolligs J, Jungehuelsing M, et al. Prevalence, distribution and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer. 2001; 92: 2875-84.10.1002/1097-0142(20011201)92:11<2875::AID-CNCR10130>3.0.CO;2-7Open DOISearch in Google Scholar

11. Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J, et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res. 2011; 17:6262-71.10.1158/1078-0432.CCR-11-0388Open DOISearch in Google Scholar

12. Khovidhunkit SO, Buajeeb W, Sanguansin S, Poomsawat S, Weerapradist W. Detection of human papillomavirus in oral squamous cell carcinoma, leukoplakia and lichen planus in Thai patients. Asian Pac J Cancer Prev. 2008; 9:771-5.Search in Google Scholar

13. Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM. A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev. 2010; 19:574-87.10.1158/1055-9965.EPI-09-0981Open DOISearch in Google Scholar

14. Waitzberg AF, Nonogaki S, Nishimoto IN, Kowalski LP, Miguel RE, Brentani RR, et al. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas. Cancer Detect Prev. 2004; 28:178-86.10.1016/j.cdp.2004.02.00315225897Open DOISearch in Google Scholar

15. Jayasurya R, Sathyan KM, Lakshminarayanan K, Abraham T, Nalinakumari KR, Abraham EK, et al. Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. Mod Pathol. 2005; 18:1056-66.10.1038/modpathol.380038715731778Open DOISearch in Google Scholar

16. De Paula AM, Souza LR, Farias LC, Correa GT, Fraga CA, Eleuterio NB, et al. Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization. Oral Oncol. 2009; 45:777-82.10.1016/j.oraloncology.2008.11.01519359212Search in Google Scholar

17. Stoll C, Baretton G, Ahrens C, Lohrs U. Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma. Virchows Arch 2000; 436:102-8.10.1007/PL00008207Search in Google Scholar

18. Lo Muzio L, Mignogna MD, Pannone G, Rubini C, Grassi R, Nocini PF, et al. Expression of bcl-2 in oral squamous cell carcinoma: an immunohistochemical study of 90 cases with clinico-pathological correlations. Oncol Rep. 2003; 10:285-91.10.3892/or.10.2.28512579259Search in Google Scholar

19. de Vicente JC, Olay S, Lequerica-Fernandez P, Sanchez-Mayoral J, Junquera LM, Fresno MF. Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma. J Oral Pathol Med. 2006; 35:140-5.10.1111/j.1600-0714.2006.00378.x16454809Open DOISearch in Google Scholar

20. Zhang M, Zhang P, Zhang C, Sun J, Wang L, Li J, et al. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma. J Oral Pathol Med. 2009; 38:307-13.10.1111/j.1600-0714.2008.00689.x18710422Open DOISearch in Google Scholar

21. Teni T, Pawar S, Sanghvi V, Saranath D. Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India. Pathol Oncol Res. 2002; 8:109-14.10.1007/BF0303371912172574Open DOISearch in Google Scholar

22. Camisasca DR, Honorato J, Bernardo V, da Silva LE, da Fonseca EC, de Faria PA, et al. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Oncol. 2009; 45:225-33.10.1016/j.oraloncology.2008.05.02118715811Open DOISearch in Google Scholar

23. Yang L, Zhu X, Ran L. Correlations of HER-2, PCNA, Bcl-2, and Bax expression to prognosis of breast cancer. Ai Zheng. 2007; 26:756-61.Search in Google Scholar

24. Tsamandas AC, Kardamakis D, Petsas T, Zolota V, Vassiliou V, Matatsoris T, et al. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients’ outcome. In Vivo. 2007; 21:113-8.Search in Google Scholar

25. Zinkel S, Gross A, Yang E. BCL2 family in DNA damage and cell cycle control. Cell Death Differ. 2006; 13: 1351-9.10.1038/sj.cdd.440198716763616Open DOISearch in Google Scholar

26. Brady HJ, Gil-Gomez G, Kirberg J, Berns AJ. Bax alpha perturbs T cell development and affects cell cycle entry of T cells. EMBO J. 1996; 15:6991-7001. 10.1002/j.1460-2075.1996.tb01091.xSearch in Google Scholar